Grown Rogue International Inc GRUSF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.65
- Day Range
- $0.64–0.72
- 52-Week Range
- $0.12–0.72
- Bid/Ask
- $0.68 / $0.72
- Market Cap
- $129.22 Mil
- Volume/Avg
- 464,583 / 209,976
Key Statistics
- Price/Earnings (Normalized)
- 36.01
- Price/Sales
- 4.82
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Grown Rogue International Inc is a vertically integrated, multi-state Cannabis family of brands. The company creates creative products with consumer insight-based product categorization in both indoor and outdoor manufacturing facilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Growth
- Total Number of Employees
- 204
- Website
- https://www.grownrogue.com
Valuation
|
Metric
|
GRUSF
|
|---|---|
Price/Earnings (Normalized) | 36.01 |
Price/Book Value | 10.26 |
Price/Sales | 4.82 |
Price/Cash Flow | 17.58 |
Price/Earnings
GRUSF
Financial Strength
|
Metric
|
GRUSF
|
|---|---|
Quick Ratio | 0.84 |
Current Ratio | 1.34 |
Interest Coverage | 0.79 |
Quick Ratio
GRUSF
Profitability
|
Metric
|
GRUSF
|
|---|---|
Return on Assets (Normalized) | 13.77% |
Return on Equity (Normalized) | 32.93% |
Return on Invested Capital (Normalized) | 24.77% |
Return on Assets
GRUSF
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Jxjcxjkqsl | Vbjntt | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Wjfhgnrzy | Xrfm | $68.9 Bil | |
HLN
| Haleon PLC ADR | Kvcmjdkdd | Ccg | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Crspbls | Vyyqm | $14.7 Bil | |
VTRS
| Viatris Inc | Dbjwdtlbb | Rwzdc | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jrzbyltm | Tyz | $11.9 Bil | |
CTLT
| Catalent Inc | Yyglpjjy | Sfwkn | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Fxbvyng | Hfsvh | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Nhdltkflx | Dpzn | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Ywcplshfb | Lmkghn | $3.5 Bil |